JP2025502602A5 - - Google Patents
Info
- Publication number
- JP2025502602A5 JP2025502602A5 JP2024529739A JP2024529739A JP2025502602A5 JP 2025502602 A5 JP2025502602 A5 JP 2025502602A5 JP 2024529739 A JP2024529739 A JP 2024529739A JP 2024529739 A JP2024529739 A JP 2024529739A JP 2025502602 A5 JP2025502602 A5 JP 2025502602A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- alkylene
- ring
- alkyl group
- membered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111583828.0 | 2021-12-22 | ||
| CN202111583828 | 2021-12-22 | ||
| CN202210098381 | 2022-01-27 | ||
| CN202210098381.6 | 2022-01-27 | ||
| CN202210562007.7 | 2022-05-23 | ||
| CN202210562007 | 2022-05-23 | ||
| CN202211568373 | 2022-12-07 | ||
| CN202211568373.X | 2022-12-07 | ||
| PCT/CN2022/140669 WO2023116761A1 (zh) | 2021-12-22 | 2022-12-21 | 嘧啶杂环化合物，其制法与医药上的用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025502602A JP2025502602A (ja) | 2025-01-28 |
| JP2025502602A5 true JP2025502602A5 (enExample) | 2025-12-18 |
Family
ID=86901286
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024529739A Pending JP2025502602A (ja) | 2021-12-22 | 2022-12-21 | ピリミジン複素環式化合物、その調製方法及び医薬用途 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250145632A1 (enExample) |
| EP (1) | EP4455132A4 (enExample) |
| JP (1) | JP2025502602A (enExample) |
| KR (1) | KR20240124992A (enExample) |
| CN (1) | CN118647607A (enExample) |
| AR (1) | AR128066A1 (enExample) |
| TW (1) | TW202340211A (enExample) |
| WO (1) | WO2023116761A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118556065A (zh) * | 2022-01-28 | 2024-08-27 | 江苏奥赛康药业有限公司 | 含吲哚的大环类化合物及其应用 |
| CN117964628A (zh) * | 2022-10-24 | 2024-05-03 | 科辉智药生物科技(深圳)有限公司 | 作为cdk9抑制剂的大环类化合物及其应用 |
| TW202500154A (zh) * | 2023-06-19 | 2025-01-01 | 香港商英矽智能科技知識產權有限公司 | 大環類化合物、包含其的藥物組合物及其在醫藥上的用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006038001A1 (en) * | 2004-10-06 | 2006-04-13 | Celltech R & D Limited | Aminopyrimidine derivatives as jnk inhibitors |
| MX358346B (es) * | 2014-04-04 | 2018-08-15 | Syros Pharmaceuticals Inc | Inhibidores de la quinasa dependiente de ciclina 7 (cdk7). |
| SG11201900328WA (en) * | 2016-07-13 | 2019-02-27 | Jason Marineau | Inhibitors of cyclin-dependent kinase 7 (cdk7) |
| CA3088529A1 (en) * | 2018-01-16 | 2019-07-25 | Syros Pharmaceuticals, Inc. | Inhibitors of cyclin-dependent kinase 7 (cdk7) |
| EP3873462A4 (en) | 2018-11-01 | 2022-08-03 | Syros Pharmaceuticals, Inc. | CANCER TREATMENT METHODS IN BIOMARKER-IDENTIFIED PATIENTS WITH NON-COVALENT INHIBITORS OF CYCLINE-DEPENDENT KINASE 7 (CDK7) |
| US20230115945A1 (en) * | 2019-12-30 | 2023-04-13 | Tyra Biosciences, Inc. | Aminopyrimidine compounds |
| CN118556065A (zh) * | 2022-01-28 | 2024-08-27 | 江苏奥赛康药业有限公司 | 含吲哚的大环类化合物及其应用 |
-
2022
- 2022-12-21 EP EP22910073.0A patent/EP4455132A4/en active Pending
- 2022-12-21 WO PCT/CN2022/140669 patent/WO2023116761A1/zh not_active Ceased
- 2022-12-21 KR KR1020247023947A patent/KR20240124992A/ko active Pending
- 2022-12-21 US US18/721,125 patent/US20250145632A1/en active Pending
- 2022-12-21 AR ARP220103549A patent/AR128066A1/es unknown
- 2022-12-21 CN CN202280076515.2A patent/CN118647607A/zh active Pending
- 2022-12-21 TW TW111149289A patent/TW202340211A/zh unknown
- 2022-12-21 JP JP2024529739A patent/JP2025502602A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2022187528A1 (en) | Quinazoline amine derivatives as kras inhibitors | |
| CA3060416A1 (en) | Combination therapies with ehmt2 inhibitors | |
| CN109476663A (zh) | 用于治疗癌症的吡唑并吡啶衍生物 | |
| HUP0400017A2 (hu) | Antibakteriális hatóanyakokként alkalmazható nitrogéntartalmú biciklusos heterociklusos vegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| EP3364968A1 (en) | Oxazolidinone compounds and methods of use thereof as antibacterial agents | |
| WO2019136244A1 (en) | Heterocyclic compounds for the treatment of abnormal cellular proliferation | |
| AU2016368317A1 (en) | Inhibitors of influenza virus replication, application methods and uses thereof | |
| JP2019510787A5 (enExample) | ||
| RU2015149009A (ru) | 19-нор нейроактивные стероиды и способы их применения | |
| CA2709776A1 (en) | Substituted pyrrolo[2, 3-b] and pyrazolo[3, 4-b] pyridines for use as adenosine receptor ligands | |
| US20120196870A1 (en) | Combination therapy and cancer | |
| CA2538915A1 (en) | [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia | |
| CA3167023A1 (en) | Sulfonimidamide compounds as nlrp3 modulators | |
| RU2005136370A (ru) | Трициклические индоловые производные и их применение в лечении болезни альцгеймера | |
| RU2008141239A (ru) | Соединения тетрагидропиридотиенопиримидина и способы их применения | |
| WO2011050284A1 (en) | Pyrazolylpyridine antiviral agents | |
| JP2014528436A5 (enExample) | ||
| JP2016513108A5 (ja) | 治療用化合物 | |
| FI3909584T3 (fi) | Pyrimidiiniyhdiste tai sen suola | |
| JP2021524856A5 (enExample) | ||
| CN115785186A (zh) | 甾体化合物及其应用 | |
| TNSN05080A1 (en) | NOVEL ANTIMYCOBACTERIAL COMPOUNDS (as filed) AND PYRROLE DERIVATIVES AS ANTIMYCOBACTERIAL COMPOUNDS (as published) | |
| JP7498702B2 (ja) | Ｔｌｒ８アゴニスト | |
| CN106456645A (zh) | 用于放射性标记的方法和试剂 | |
| RU2004114278A (ru) | Амид 8-амино-[1.2.4]триазоло-[1.5-а]пиридин-6-карбоновой кислоты |